Could insulin eye drops save your sight? new trial launches

NCT ID NCT07619482

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether insulin eye drops can protect the optic nerve in people with open-angle glaucoma. Researchers will give 90 participants either insulin drops or placebo daily for up to 12 months. The main goal is to check safety, but they will also measure vision changes and eye structure.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

topical sterile human insulin eye drops (EYED-002)

What this could lead to

If successful, this could provide a new way to protect the optic nerve and slow vision loss in glaucoma patients.

What could go wrong

This is an early-phase trial focused on safety, so it may not show clear benefit. Insulin eye drops could cause eye irritation or affect blood sugar.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OPEN ANGLE GLAUCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

exfoliation syndrome glaucoma low tension glaucoma open-angle glaucoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Byers Eye Institute at Stanford University

    Palo Alto, California, 94303, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••